Remove 2023 Remove Disease Remove Electronic Medical Record Remove Imaging
article thumbnail

Natural Language Processing (NLP) in Spotlight at HIMSS 2023

Imaging Technology

The Boston, MA-based company has announced multiple sessions to demonstrate its industry-leading Clinical Natural Language Understanding (cNLU) technology at HIMSS 2023. The most common conditions the NLP pipeline captured that the anesthesiologist did not include cardiac arrhythmias, angina, anticoagulation, and neuromuscular disease.

article thumbnail

New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy

Imaging Technology

milla1cf Tue, 04/11/2023 - 21:23 April 11, 2023 — To meet the needs of non-acute healthcare, a global health advocate is launching a newly modernized digital maturity model. It focuses on wellness, illness prevention, and the use of technology to help manage chronic disease at home and keeping patients out of the hospital.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Synoptic Reporting Improves Pretreatment CT for Advanced Ovarian Cancer

Imaging Technology

Meanwhile, 77 reports generated after April 1, 2020 used a synoptic report—list of 45 anatomic sites relevant to ovarian cancer management, each classified in terms of disease absence versus presence. Gynecologic oncology surgeons were electronically surveyed.

article thumbnail

C-COMM: HIMSS New Non-Acute Care Digital Maturity Model

Imaging Technology

milla1cf Fri, 04/21/2023 - 22:45 April 21, 2023 — To meet the needs of non-acute healthcare, HIMSS is launching a newly modernized digital maturity model, Community Care Outcomes Maturity Model (C-COMM). For more information: www.himss.org Find more HIMSS23 conference coverage here Friday, April 21, 2023 - 22:45

article thumbnail

Biomarker model predicts breast cancer risk without racial bias

AuntMinnie

Lamb and colleagues sought to assess the performance of an image-based deep learning risk assessment model for predicting both future invasive breast cancer and ductal carcinoma in situ (DCIS) across multiple races. Image and caption courtesy of RSNA. for White women, with lower performance in women of other races.

article thumbnail

Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual Meeting

Imaging Technology

Since immunotherapy has proved beneficial for patients with advanced disease, this study assessed whether adding immunotherapy to chemotherapy and radiation could improve pathologic complete response (pCR) at surgery for patients with less-advanced esophageal cancer. Also, Lynn M. CT in Hall D1.

Clinic 111
article thumbnail

Predictions for Healthcare AI Entering 2023

Aidoc

Whether it be unleashing genomic sequencing to personalize oncologic treatments or developing an electronic medical records system, the healthcare industry as a whole abides by the highest standards of testing and evaluation prior to welcoming novel solutions that may impact patient lives.